Semaglutide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, and slows gastric emptying
Retatrutide adds a third mechanism that may provide even better results, though it remains unavailable outside research studies
Once all the above steps have been taken
Yes, diarrhea rates are higher with retatrutide (9-35% depending on dose and study) compared to semaglutide (8-15%) and tirzepatide (moderate rates between the two)
Ozempic and Wegovy are semaglutides, synthetic versions of GLP-1 that regulate blood sugar and signal fullness, while Mounjaro and Zepbound are tirzepatides, which mimic GLP-1 and also act on a second hormonal pathway, GIP, or glucose-dependent insulinotropic polypeptide, potentially enhancing their effects
This peptide should not be used if you are pregnant or breastfeeding high blood sugar dose